SBC Medical Q3 revenue $53M (+12% YoY); net income falls to $2M from $8M

SBC Medical Group Holdings Inc

2024-Q3 EPS reported $0.42 revenue$160,995,005

Q3 revenue $53M (+12% YoY); operating income $13M (-31% YoY, hit by $12.8M stock-based comp).
Q3 net income attributable to SBC was $2M vs $8M in Q3 2023; nine-month net income $40M (+60%).
Nine-month revenue $160M (+23%), EBITDA $68M (+21%), EBITDA margin 42%.
Partner clinics reached 224 as of Sep 30, 2024, up 24 from a year ago.
Stock-based compensation of $12.8M in Q3 related to listing process reduced operating income.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.